4-Isothiocyanatobenzenesulfonamide

Catalog No. :
ACVRQD027
CAS No. :
51908-29-3
Molecular Formula :
C7H6N2O2S2
Molecular Weight :
214.27

IUPAC Name:4-isothiocyanatobenzenesulfonamide

4-Isothiocyanatobenzenesulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$192.00Login to see priceInquiryInquiry
25g95%$747.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Isothiocyanatobenzenesulfonamide
IUPAC Name4-isothiocyanatobenzenesulfonamide
MDL No.MFCD00079768
Molecular FormulaC7H6N2O2S2
Molecular Weight214.27
SMILESO=S(C1=CC=C(N=C=S)C=C1)(N)=O
InChI KeyIMDUFDNFSJWYQT-UHFFFAOYSA-N
Synonym4-Isothiocyanatobenzenesulfonamide | 51908-29-3 | 4-isothiocyanatobenzene-1-sulfonamide | Benzenesulfonamide, 4-isothiocyanato- | 4-Isothiocyanato-benzenesulfonamide | JA8KJ8MS2S | CHEMBL144818 | 4-lsothiocyanatobenzenesulfonamide | 4-Isothiocyanatobenzene sulfonamide | 4-
CAS No.51908-29-3
PubChem CID521359

Safety Data

Pictogram
Health hazardToxic
Signal Word
Danger
Hazard Statement(s)
H301
Precautionary Statement(s)
P261-P264-P270-P271-P280-P285-P301+P310+P330-P302+P352-P304+P340+P312-P305+P351+P338-P332+P313-P337+P313-P342+P311-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACVRQD027 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYKIP713 route compound structure diagram
    ACYKIP7136101-31-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVRQD027 route product structure diagram
    ACVRQD02751908-29-3
Inquiry

2. ACVRQD027 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYKIP713 route compound structure diagram
    ACYKIP7136101-31-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVRQD027 route product structure diagram
    ACVRQD02751908-29-3
Inquiry

Comments (0)